Join the Macular Degeneration group to help and get support from people like you.
Macular Degeneration News
Related terms: Blurry Vision
Robotic Procedure Helps Treat Macular Degeneration
THURSDAY, June 12, 2024 – Robot-guided radiation therapy can improve treatment for age-related macular degeneration, the leading cause of vision loss and blindness among American seniors, a new...
Robotic Procedure Helps Treat Macular Degeneration
THURSDAY, June 12, 2024 – Robot-guided radiation therapy can improve treatment for age-related macular degeneration, the leading cause of vision loss and blindness among American seniors, a new...
Melatonin Use Linked to Reduced Risk for Development, Progression of AMD
TUESDAY, June 11, 2024 – Melatonin use is associated with a reduced risk for development and progression of age-related macular degeneration (AMD), according to a study published online June 6 in...
FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea
May 20, 2024 – The U.S. Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept products work by inhibiting...
FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea
May 20, 2024 – The U.S. Food and Drug Administration (FDA) has approved Opuviz (aflibercept-yszy), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept products work by inhibiting...
Home Vision Tests Offer Limited Diagnostic Accuracy for Neovascular AMD
MONDAY, April 29, 2024 – No home-monitoring vision test has the diagnostic accuracy of hospital eye service follow-up clinics to identify active neovascular age-related macular degeneration (nAMD),...
Minocycline Does Not Decrease Geographic Atrophy Enlargement in AMD
MONDAY, March 25, 2024 – Oral minocycline is not associated with a decrease in geographic atrophy (GA) enlargement in patients with age-related macular degeneration (AMD), according to a study...
Diagnosed With Macular Degeneration? Here's What You Need to Know
TUESDAY, Feb. 6, 2024 – Age-related macular degeneration can lead to vision loss in seniors, but new therapies have offered fresh hope for preserving eyesight later in life, eye experts say. These...
Does More Outdoor Light at Night Help Cause Macular Degeneration?
TUESDAY, Jan. 16, 2024 – As levels of nighttime artificial outdoor light rise, so do the odds for a leading cause of vision loss, age-related macular degeneration (AMD). South Korean researchers...
Does More Outdoor Light at Night Help Cause Macular Degeneration?
TUESDAY, Jan. 16, 2024 – As levels of nighttime artificial outdoor light rise, so do the odds for a leading cause of vision loss, age-related macular degeneration (AMD). South Korean researchers...
Poor Vision & Falls: A Deadly Combo for Seniors
FRIDAY, Dec. 29, 2023 – Seniors with vision issues are at much higher risk for dangerous falls, new research confirms. Compared to seniors with good vision, the odds for a fall rose by 38% for...
Burden of Visual Impairment Has Increased Globally
TUESDAY, Dec. 12, 2023 – The number of prevalent cases of visual impairment globally increased substantially in working-age individuals from 1990 to 2019, according to a study published online Dec....
AI Model Can Respond Appropriately to Ophthalmology Questions
FRIDAY, Aug. 25, 2023 – Large language models (LLMs) like ChatGPT can respond to patient-written ophthalmology questions and usually generate appropriate responses, according to a study published...
FDA Approves Eylea HD (aflibercept) Injection 8 mg for Treatment of Wet Age-related Macular Degeneration (wAMD), Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR)
TARRYTOWN, N.Y., Aug. 18, 2023 (GLOBE NEWSWIRE) – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Eylea HD (aflibercept)...
FDA Approves Izervay for Geographic Atrophy Tied to Age-Related Macular Degeneration
WEDNESDAY, Aug. 9, 2023 – The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related...
Ask a question
To post your own question to this support group, sign in or create an account.